论文部分内容阅读
德国柏林夏里特医疗中心的一个研究小组采用分子医学纳米技术,发明了新的抗癌疗法.由安德烈亚·约尔丹领导的研究小组发明的抗癌新疗法是对普通磁疗法的重大技术改进.普通磁疗法利用电磁场对肿瘤部位进行加热,当温度高于40℃,可以破坏癌细胞,但同时也损害到肿瘤周边的健康组织.新的磁疗法是将细微的铁氧体粒子用葡聚精分子包裹,在水中溶解后注入肿瘤部位,癌细胞和磁性纳米粒子浓缩在一起,肿瘤部位完全被磁场封闭.这样通电加热时,肿瘤部位的温度可以达到47℃,慢慢杀死癌细胞,而临近的健康组织丝毫不受影响.铁氧体纳米粒子在治疗结束后可以通过人体肝脏和脾脏自然排泄,精确的定向磁疗法不会对病人产生副作用.第一台新的磁疗系统目前已安装在柏林夏里特医疗中心,今年秋季将正式开始用于临床治疗.此前,研究小组利用新的磁疗法对患有乳腺肿瘤的实验鼠做了试验,肿瘤在一个半小时治疗后完全消失,效果非常明显.未来对人体的临床治疗首先用于成胶质细胞瘤然后根据治疗效果,逐步推广到治疗其他肿瘤.约尔丹课题小组下一步还计划研究使纳米粒子直接通过血管输送到目的地,这个设想是基于纳米粒子对于确定的表面活性的癌细胞起作用,对正常细胞不起作用.如果这项研究成功,则甚至可以追踪和消灭转移的癌细胞.
A research group at the Charlotte Medical Center in Berlin, Germany, invented new anticancer therapies using molecular nanotechnology, a new anti-cancer therapy invented by Andrjahl Jordin’s research team, Major technical improvements.General magnetic therapy using electromagnetic fields to heat the tumor site, when the temperature is higher than 40 ℃, can destroy cancer cells, but also damage to the surrounding tissue of the tumor.The new magnetic therapy is the fine ferrite particles Plum polyglutamine molecules wrapped in water dissolved into the tumor site, cancer cells and magnetic nanoparticles together, the tumor site was completely closed by the magnetic field so energized heating, the temperature of the tumor site can reach 47 ℃, and slowly kill Cancer cells, and the adjacent healthy tissue was not affected at all Ferrite nanoparticles can be naturally excreted by the human liver and spleen after the treatment, precise and targeted magnetic therapy will not have side effects on patients The first new magnetic system Has now been installed at the Charlotte Medical Center in Berlin and will begin its clinical treatment this fall. Previously, the team used new magnetic therapies to treat patients with Gland tumor mice were tested, the tumor completely disappeared after an hour and a half treatment, the effect is very obvious. The future clinical treatment of human first for glioblastoma and then based on the therapeutic effect, and gradually extended to treat other tumors. The Danian task force next plans to study the delivery of nanoparticles directly through the bloodstream to their destination, based on the idea that nanoparticles act on defined surface-active cancer cells and not on normal cells. If the study is successful, The metastatic cancer cells can even be tracked and eliminated.